X

COVID-19: Frequently Asked Questions

Below are some of the most frequently asked questions CMA has received during the COVID-19 outbreak. By default, the most recent answers will appear up top. You can also filter the FAQ by category. We will update this resource regularly.

More questions? Email communications@cmadocs.org.


Filter FAQ by Category

 

Has the Federal Anti-Kickback Statute been waived because of the COVID-19 pandemic?

posted on

Yes. On April 3, 2020, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued a policy statement of enforcement discretion regarding applicable sanctions under the Federal Anti-Kickback Statute (42 U.S.C. Section 1320a-7b). The Policy Statement is designed to bring Anti-Kickback Statute enforcement in line with the CMS’ blanket waivers regarding sanctions under Stark Law.

The Policy Statement says OIG will not impose sanctions under the Anti-Kickback Statute with respect to remuneration that is covered by Section II.B(1)-(11) of CMS’s blanket waivers. The Policy Statement is silent on Section II.B(18) of the blanket waiver which suspends the writing and signature requirements for certain Stark law exceptions.

The Policy Statement does not expand the CMS blanket waivers. The OIG expressly points out that the enforcement discretion does not apply to “arrangements… that are not covered by the Blanket Waivers (e.g., direct financial relationships between pharmaceutical or device manufacturers and physicians or between providers where there is no physician involved).”

The Policy Statement only applies to conduct on or after April 3, 2020, while CMS’s blanket waivers are retroactive to March 1, 2020. The Policy Statement remains in effect till the termination of CMS’ Blacker Waivers.

Additional questions regarding this matter can be directed to OIGComplianceSuggestions@oig.hhs.gov.

Source: OIG Policy Statement

| Categories: Fraud and Abuse | Return

Search the FAQ

FAQ Categories

Subscribe to FAQ

Get notified immediately when we publish a new FAQ.

Name

Terms of Use

Your use of the CMA website, including information provided on the COVID 19 Resource Page is governed by the Terms of Use and Privacy Policy linked below.  All CMA Content, including COVID 19 related content, is provided for informational purposes only and is not intended as medical or legal advice, or as a substitute for the medical advice of a physician or the legal advice of an attorney. Physicians should contact their professional liability and other insurers and an attorney for specific advice.

Not a CMA member?

Join nearly 50,000 physicians making a direct impact on the practice of medicine and the health of California.